TechnoBusiness-Solutions.com
Where Powerful Methods Originate and Produce Breakthrough Results

 

Intellectual Property and Technology Transfer: How To Basics,Royalties,Licensing,Due Diligence,Intellectual Property Evaluation, Assessment,Invention Brokers,Consultants,Medical Devices,Pharmaceuticals,Diagnostics,Buyers,Sellers,Idea Commercialization,New Ventures

 

intellectual property,technology transfer,due diligence,licensing,royalties,invention brokers,new venturesconsultants,medical devices,pharmaceuticals,diagnostics,medical,healthcare,invention brokers,technology transfer,intellectual property,royalties

 

medical device consultants,pharmaceutical consultants,biomedical,diagnosticsSearch Our Website


 
 

What Is Technology Transfer?


Is the process by which technology, knowledge, or information (Intellectual Property or IP) developed in one organization, in one area, or for one purpose is applied or used in another organization, or area, or for another purpose.  Broadly speaking, it is the process by which an IP gets converted into a product or service that the end user accepts and uses. This IP could be in any phase of its product commercialization cycle, i. e. a) the elementary or "embryonic" phase, product development phase, and well advanced, "near market" and ready for exploitation phase.
 

The Ten Commandments of Technology Transfer



1. Establish realistic, clear and concise objectives, anticipated benefits and project plan with associated resources. Begin by writing a clear and concise SOP of your new drug.

2. Gain senior management's approval and committed support throughout the technology transfer process. Thereafter, keep them engaged until the successful commercialization of your product by having all communication channels open.

3. Establish a "win-win" relationship with all your internal customers, i. e. Senior management, Marketing, Research, Engineering, Legal, Corporate Finance, Manufacturing, and external customers,  i. e. end user of the product, patient, primary and secondary decision makers in purchasing your new product, suppliers, vendors, contract manufacturers. 

Be open, direct, innovative and creative with all forms of your communication. 

Don't allow adversarial relationships to develop between the partners of your technology transfer formulation. 

When in New York, learn to conduct business as a New Yorker.

4. Engage the FDA and other regulatory agencies early on, deal with them "straight" and keep them involved until your project succeeds. 

Set-up a "mock jury" to review your drug application just before submitting. 

Make your drug application clear, concise and user friendly.

5. Protect your intellectual property with well written legal agreements and by avoiding inadvertent disclosure. When in doubt, consult with your legal experts.

6. Conduct pilot and other scientific studies utilizing experimental design and other statistical tools, and correctly interpret the generated data. Investigate all abnormalities.

Quote from unknown Clinical Director: "I don't do windows, doors or uncontrolled studies." 

7. Write and report facts faithfully and fully following the 5C's of a flawless diamond - cut, clarity, clear, carat. 

Develop concise and compact protocols and reports. 

Check and certify everything enthusiastically: Audit, review, sign and date all documents. 

8. Form a technology transfer team having a blend of experiences and expertise, then empower them with the responsibility to make your new product project a commercialization success. 

Identify the decisions, actions, outputs and deliverables that each team would be responsible for. 

Identify the training, facilitation, coaching and assessment that each team would receive. 

Identify the support the team leaders, coordinators and managers will receive to let and help them perform their functions successfully. 

Combine all resources and/or capabilities for the ultimate success of the project.

Agree on thresholds for market size, pricing, and product placement.

Arrange transition through organizational units of similar scope and scale.

Understand and hopefully share perceptions and assessments of risk.

Agree on priorities and levels of commitment. 

Remember that showing cannot be done with words, alone; it requires action (seeing, touching, smelling, tasting or measuring).  "Don't tell me what you have done.  Show me!"

Famous Quotations:

People who work together will win. Vince Lombardi, 1964

A long pull, a strong pull, and a pull all together.  Charles Dickens, 1849

All for one, one for all, that is our motto. The Three Musketeers, 1844

Nothing great was ever achieved without enthusiasm.  Ralph Waldo Emerson, 1841

9. Monitor, manage and control your project's progress by "on site", hands-on visits at the manufacturing lab, customers, etc. and electronic means as well as brief but frequent project status presentations.

Document both triumphs and mistakes made in parallel with the completion of each project phase. 

Bring-in early and educate thoroughly the team that will pick-up and continue work on the project after you. Then, stay in touch until the new team feels totally comfortable to move on independently. 

Address perceived risks arising from market and business uncertainties. Include risks' appraisal to all product development and commercialization investment decisions.
 

10. Constantly re-evaluate the business and technical merits of the new project as external and/or internal conditions change. 

Justify investment in technology development only on the basis of market data. Engineering success, field tests, and technology demonstrations can only produce commercial development after filtering through screens of market analysis and calculations of return on investment. Prospects for direct technology transfer significantly improve when market information gets supplemented with technical data. 

Do not be afraid to pull the plug if and/or when the project proves itself to be "dead."  Document user needs, market size, vital industry data (market-specific purchasing decision criteria), major points of product differentiation tied to industry's vital points, pricing strategy, analysis of best practices and trend forecasts, identification of market barriers, analysis of competition and substitution options.
 

What is Due diligence?


Due diligence is a process to gain and verify needed information relative to a possible acquisition or merger. Each of these analyses get customized to the needs of the particular deal to increase understanding, ensure that the business operates as projected and to look for hidden problems. 

Due diligence is also a process of obtaining sufficiently reliable information about a business entity to help uncover any fact, circumstance or set of conditions that would have a reasonable likelihood of influencing our client’s offer or decision to acquire the business.

Generally, issues relating to financial statements, personnel, processes and procedures, products and services, customers, suppliers, government compliance, legal, competition and the industry are addressed. 

The internally generated information obtained during the due diligence process will help our client:

  • Verify seller representations. 
  • Assist in the determination of value (assets and liabilities.) 
  • Uncover problems, issues and concerns (current and future.) 
  • Gain a better understanding of the business, industry, key customers, trends and regulatory requirements. 
  • Evaluate management and key employees. 

Externally generated information will focus on:

  • Public information regarding the company, its principals and key employees. 
  • Key customers. 
  • Market research to gain a better understanding of the dynamics of the marketplace. 

Successful completion of this type of project requires attention to the following:

  • Be aware of how the nature of the information impacts its reliability and/or compares to benchmarking standards  
    • internal vs. external 
    • how and from who it is obtained 
    • is it independently verifiable 
  • Be on the lookout for inconsistencies in verbal representations or information that are either individually or cumulatively material. 
  • Ask open ended questions. Rather than asking for the confirmation of a fact, ask a question that leads you to the same answer. 
  • Remember that in many instances past behavior can be a good predictor of future performance. This can be crucial in evaluating management’s and employee’s values, practices and performance. 

Caution: Due diligence may not and probably will not uncover fraud or a conspiracy to commit fraud. We recommend that our client always has the seller sign a representation letter prior to closing the deal ( POSITIVE - confirming all the representations the seller has made ; NEGATIVE - no known facts or circumstances that would affect your decision to buy the company under the terms and conditions agreed upon.)
.

Our Due Diligence Template


We utilize a methodology template which evaluates a company according to desirable client criteria. We formulate and implement a tailor-made due diligence plan, when we have clearly understood your current project needs. These criteria might include the following:

  • Twenty two pre-visit, screening criteria. 
  • Fifteen check points related to safety and environmental management controls. 
  • Twenty four check points related to intellectual property, technology, operational performance, quality and profitability. 

What is Valuation?


Valuation is the method for establishing the overall value of either an existing business or new intellectual property (IP.)
 

Technology and Business Assessment for Established Business


.
Upon conclusion of a technology and business assessment project our client receives a report containing the following: 

  • Strength of specific product technology versus the unmet needs of the customer.  
  • Size of business opportunity as compared to current and future competitors. 
  • Product's ability to satisfy government, FDA and/or other regulatory issues. 
  • Manufacturing and market penetration strategies.  
  • Reliance on patents and protection of proprietary technology. 
  • Depth of in-house technical expertise and strength of management team. 
  • Company's track record from start-up date to date in achieving its originally defined project objectives.  

Technology and Business Assessment of New Intellectual Property


Our typical report includes:

  • Scientific merit of the invented technology. 
  • List of possible, technical obstacles which would need to be overcome for successful  product development, manufacture and commercialization. 
  • Relative strength of the invention as compared to other patented technologies. 
  • Potential applications of the subject technology. 
  • Estimated size of the various market segments, environmental and regulatory trends (if any), major players, etc. 
  • Overall assessment of the invention's technical and business merit. 

How do I evaluate the value of the technologies I have?


We normally complete two technical and business feasibility studies for every promising Intellectual Property (IP.)

The first study is exploratory yet complete enough to tell us if the subject IP warrants further investigation and allocation of resources.

If the IP passes the first test, then we determine what requirements does the IP needs to satisfy and by when in order to take another, more thorough look at its technical and business merit.

Upon successful completion of these two hurdles, the subject IP is considered worthy of its own business plan for development, manufacture and/or commercialization.

In our experience, a majority of IPs would never pass this phase if they were to be evaluated correctly, thereby wasting valuable, scarce resources that could have been better applied to the truly worthy IPs.

We have developed a number of proprietary templates which minimize such pitfalls and significantly increase one's likelihood to evaluate correctly the merit of an IP.
 

How do I find a prospective market?


This question is partly addressed above. That is, successful completion of Phase One will include the identification and evaluation of the potential market opportunities, present market entrants and their relative strengths/weaknesses, unmet customer needs, environmental and other regulatory trends, etc. It is a clear, objective road map.

Once you know who the key players are, then it is much easier to approach them.

A very important element in this first phase is to be creative, innovative and practical. It is like trying to figure out if your three (3) month old baby is more suitable to be an engineer, artist or priest. This activity requires experience and other innate skills.
 

Should I find an "agent" to help me find buyers?


Once you know the relative value of your IP, then you must determine if you have in-house the required resources for commercializing the subject IP.

In today's fast changing business environment, it is probably to your advantage to get the assistance of an expert to help you instead of trying to follow the "Amish" concept of learning and doing everything by yourself. That is, time is probably much more valuable than the cost (a worthy investment in my opinion) incurred to hire an expert.

It is very important to team-up with an agent using the "Win-Win" principle. The basic question needs to be: "What's in for all of us?" NOT only "What's in for me?"

You must find an agent who a) is qualified, b) clearly believes in the value of the IP (you will never sell anything that you do not believe in it), c) knows that they will be 'fairly" compensated if and/or when the IP becomes commercialized, etc. and d) is capable to contribute in improving, fine-tuning and fortifying your IP and respective products (this requirement is rather rare to find but you should always try.) That is, always look for an individual or company who are a product designer, development engineer, marketer, and salesperson not just a salesperson. I know that is a tall order but that is what is required. 
 

How do I approach a prospective buyer?


There many innovative and practical ways. However, once you identify an interested party, you must provide them with the "right stuff" or you just closed the door (at least for a while) with said company.

The right stuff includes the professional development of a promo package which provides a prospective party with easy to understand, clear and compelling evidence of the merit of said IP and why they should seriously consider it. If it is possible, have available working, functional prototype products for evaluation.

This activity could be the "kiss of death" of the IP if it is not done correctly. Again, we have developed proprietary templates for developing said promo package. It might sound very logical and simple, yet time and time again we find that people fail to execute it properly.
 

Should I "tailor" my technology for a potential buyer?


Yes. Your promotional package must be tailored first to a specific market segment and then further custom-tailored to the needs of a specific prospect. It is very similar to the development of a resume or CV.
 

How do I go about negotiating the terms of the contract?


Successful negotiation is both a science and art. The more you know about the prospective party's needs, desires, business objectives, etc., etc. the better you are going to be. Also, you must have a very clear picture of your own expectations, bottom line requirements, etc., etc. We highly recommend that said negotiations are left on the hands of experts otherwise you risk killing any potential deal and/or leaving millions of dollars on the table.
 

What are some of the licensing pitfalls of yet uncommercialized IP?


  • Many people are unwilling to share with others who have the ability to help them maximize the value of their IP by licensing and/or commercializing it. They want everything for themselves. That is foolish because at the moment they own 100% of nothing whereas if the IP where to be managed by the right people, then it could be worth many millions. 
  • People try too quickly to sell/license the IP without completing correctly the technical and business feasibility (Phase One.) So, they do not know what they have in the bag.
  • Poor promotional package for licensing the IP.
  • Not engaging qualified experts when it is absolutely a must to do so.
  • Having unrealistic royalty expectations, thereby not knowing when to say "Yes" to an offer.

What is the "right" Royalty Rate for my new technology, product?


Unless you have the required competence, we recommend that you hire an expert who could help you with the following:

  • Establish, quantitatively or semi-quantitatively, how well your technology fits into the prospective company's strategic plan. This requires complete understanding of current market size and its trend, competitive situation, environmental and regulatory trends, the strength of your patented (?) technology or other barrier to entry, the prospective company's return on investment (ROI.)  
  • Establish the relative ease for transforming your technology into a manufacturable product. 
  • Establish the customer's acceptance of your new product. Be careful if it requires major user re-educating or is quite a bit ahead of its time. 
  • Remember that royalty rates will be significantly higher if your technology is in the pharmaceuticals, biotech markets and much lower if it is aimed at highly cost competitive markets (mass production businesses with practically no entry barriers.) 
  • Recognize that today the life cycle of every product has been severely compressed, especially in hot, highly competitive markets. 
  • You should have as goal to receive a royalty rate in the one to five percent (1 to 5) % range of annual sales. That is our experience, but every situation is different. 

.

help02Click here for all links at this Web Site.

.

back_to_topReturn to the top of this page.

.

 

 Copyright © 1996 TechnoBusiness Solutions(tm). All Rights Reserved.  Disclaimer . Please report questions, problems here

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home
 

Home
Who We Are
Unique Strengths
Our Services
Projects Resume
Your Next Step
Write Us
What's New
Articles
Ask SolvWizSM For FREE 

TechnoBusiness Solutions
403 Christie Ct., Stewartsville, NJ 08886 USA
Costas B. Chantzis, CEO 


Tel.: 908.387.9276
Fax: 908.387.0447  Email
Home